These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 31625039)

  • 1. Differences in Naloxone Prescribing by Patient Age, Ethnicity, and Clinic Location Among Patients at High-Risk of Opioid Overdose.
    Kispert D; Carwile JL; Silvia KB; Eisenhardt EB; Thakarar K
    J Gen Intern Med; 2020 May; 35(5):1603-1605. PubMed ID: 31625039
    [No Abstract]   [Full Text] [Related]  

  • 2. Protecting Against Opioid Overdose: Naloxone Co-Prescribing.
    Nathan N
    Anesth Analg; 2022 Jul; 135(1):20. PubMed ID: 35709440
    [No Abstract]   [Full Text] [Related]  

  • 3. Naloxone for Opioid Overdose: Comment.
    Pattullo GG
    Anesthesiology; 2024 Apr; 140(4):856. PubMed ID: 38335034
    [No Abstract]   [Full Text] [Related]  

  • 4. Naloxone for Opioid Overdose: Comment.
    Milas BL; Varon AJ
    Anesthesiology; 2024 Apr; 140(4):857. PubMed ID: 38335038
    [No Abstract]   [Full Text] [Related]  

  • 5. Intranasal Naloxone for Opioid Overdose.
    Taylor JL; Lasser KE
    JAMA; 2024 Jan; 331(3):250-251. PubMed ID: 38127361
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Opioid Overdose Risk Factors and Naloxone Prescribing in US Adults.
    Lin LA; Brummett CM; Waljee JF; Englesbe MJ; Gunaseelan V; Bohnert ASB
    J Gen Intern Med; 2020 Feb; 35(2):420-427. PubMed ID: 31820218
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The innovative role of an "opioid overdose prevention pharmacist" at a mental health teaching hospital.
    Costa T; Zhang M
    Am J Health Syst Pharm; 2021 Feb; 78(4):292-296. PubMed ID: 33471052
    [No Abstract]   [Full Text] [Related]  

  • 8. Zimhi - a higher-dose injectable naloxone for opioid overdose.
    Med Lett Drugs Ther; 2022 Apr; 64(1648):61-62. PubMed ID: 35436775
    [No Abstract]   [Full Text] [Related]  

  • 9. Legal requirements and recommendations to prescribe naloxone.
    Haffajee RL; Cherney S; Smart R
    Drug Alcohol Depend; 2020 Apr; 209():107896. PubMed ID: 32058248
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Opioid overdose knowledge among college students compared to experienced opioid users.
    Jones JD; Avila JR; Smith MK; Martinez S
    Drug Alcohol Rev; 2024 Jan; 43(1):343-346. PubMed ID: 37920901
    [No Abstract]   [Full Text] [Related]  

  • 11. Evaluating disparities in prescribing of naloxone after emergency department treatment of opioid overdose.
    Weiner SG; Carroll AD; Brisbon NM; Rodriguez CP; Covahey C; Stringfellow EJ; DiGennaro C; Jalali MS; Wakeman SE
    J Subst Abuse Treat; 2022 Aug; 139():108785. PubMed ID: 35537918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Statewide Policy to Increase Provision of Take-Home Naloxone at Emergency Department Visits for Opioid Overdose, Rhode Island, 2018‒2019.
    Griffith J; Yorlets RR; Chambers LC; Davis CS; Wentz A; Beaudoin FL; Baird J; Samuels EA
    Am J Public Health; 2023 Apr; 113(4):372-377. PubMed ID: 36745856
    [TBL] [Abstract][Full Text] [Related]  

  • 13. "A Blessing and a Curse:" Opioid Users' Perspectives on Naloxone and the Epidemic of Opioid Overdose.
    Kline A; Mattern D; Cooperman N; Dooley-Budsock P; Williams JM; Borys S
    Subst Use Misuse; 2020; 55(8):1280-1287. PubMed ID: 32182153
    [No Abstract]   [Full Text] [Related]  

  • 14. Statewide Availability of Buprenorphine/Naloxone in Acute Care Hospitals.
    Pham S; Haigh A; Barrett E
    J Addict Med; 2022 Jan-Feb 01; 16(1):e48-e51. PubMed ID: 33758118
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The changing landscape of naloxone availability in the United States, 2011 - 2017.
    Freeman PR; Hankosky ER; Lofwall MR; Talbert JC
    Drug Alcohol Depend; 2018 Oct; 191():361-364. PubMed ID: 30195192
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Opioid Crisis, Centers for Disease Control Opioid Guideline, and Naloxone Coprescription for Patients at Risk for Opioid Overdose.
    Benzon HT; Sun EC; Chou R
    Anesth Analg; 2022 Jul; 135(1):21-25. PubMed ID: 35709441
    [No Abstract]   [Full Text] [Related]  

  • 17. Differences in Self-identification of Opioid Overdose Risk and Naloxone Perceptions Between Therapeutic and Nontherapeutic Opioid Populations.
    Ellis MS; Kasper ZA; Gold M; Cicero TJ
    J Addict Med; 2023 Mar-Apr 01; 17(2):197-205. PubMed ID: 36148998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stigma by Association: To what Extent is the Attitude Toward Naloxone Affected by the Stigma of Opioid Use Disorder?
    Adeosun SO
    J Pharm Pract; 2023 Aug; 36(4):941-952. PubMed ID: 35505618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dying alone: the sad irrelevance of naloxone in the context of solitary opiate use.
    Wojcicki JM
    Addiction; 2019 Mar; 114(3):574-575. PubMed ID: 30461114
    [No Abstract]   [Full Text] [Related]  

  • 20. Community-based naloxone coverage equity for the prevention of opioid overdose fatalities in racial/ethnic minority communities in Massachusetts and Rhode Island.
    Nolen S; Zang X; Chatterjee A; Behrends CN; Green TC; Kumar A; Linas BP; Morgan JR; Murphy SM; Walley AY; Yan S; Schackman BR; Marshall BDL
    Addiction; 2022 May; 117(5):1372-1381. PubMed ID: 34825427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.